[Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer].

MLA

Saitoh, S., et al. “[Clinical Usefulness of Monoclonal Antibody, CA 125 and CA 19-9 in Ovarian Cancer].” Nihon Gan Chiryo Gakkai Shi, vol. 19, no. 10, Dec. 1984, pp. 2327–35. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=6598184&authtype=sso&custid=ns315887.

APA

Saitoh, S., Nakanishi, A., Noda, T., Ando, Y., Katakami, Y., Kiyozuka, Y., Moriyama, I., & Ichijo, M. (1984). [Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer]. Nihon Gan Chiryo Gakkai Shi, 19(10), 2327–2335.

Chicago

Saitoh, S, A Nakanishi, T Noda, Y Ando, Y Katakami, Y Kiyozuka, I Moriyama, and M Ichijo. 1984. “[Clinical Usefulness of Monoclonal Antibody, CA 125 and CA 19-9 in Ovarian Cancer].” Nihon Gan Chiryo Gakkai Shi 19 (10): 2327–35. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=6598184&authtype=sso&custid=ns315887.